Havencrest Announces Majority Investment in Tekton Research
Dallas-based Havencrest Capital Management has announced a majority investment in Tekton Research, LLC. According to data captured in the LevinPro HC database, this transaction represents the 25th clinical trials acquisition of 2023. Founded in 2006 and headquartered in Austin, Texas, Tekton Research is a clinical trial site network with 23 sites across Texas, Colorado, Georgia, Kansas and Oklahoma. Tekton conducts clinical trials across several therapeutic areas, including vaccines and infectious disease, neurology, endocrinology, immunology and dermatology, among others. Havencrest is a committed capital, lower middle-market private equity investment firm focused exclusively... Read More »
NextGen Healthcare Inks $1.6 Billion Sale to PE Firm Thoma Bravo
Private equity group Thoma Bravo has entered into an agreement to acquire NextGen Healthcare, Inc. for approximately $1.61 billion. Under the terms of the agreement, NextGen Healthcare shareholders will receive $23.95 per share in cash. NextGen Healthcare is an American software and services company headquartered in Atlanta, Georgia. The company develops and sells electronic health record (EHR) software and practice management systems to the healthcare industry. According to its most recent financial report, the company’s revenue for the fiscal year ended March 31, 2022 was $596.4 million. Thoma Bravo is a leading private equity investment firm building on a 30-plus year... Read More »
Cerba HealthCare Acquires Canadian CRO Cirion BioPharma Research
Cerba HealthCare announced on September 7 that it has acquired Cirion BioPharma Research, a contract research organization (CRO) in Laval, Quebec. Cirion BioPharma Research is a Canadian contract research laboratory providing global central laboratory services for clinical studies and research and development services. Cerba Healthcare is a leader in clinical pathology specializing in local clinical pathology, specialized clinical pathology and central lab testing for clinical trials. Its shareholders include Partners Group and the Public Sector Pension Investment Boards. Cirion will rank under Cerba HealthCare’s business unit Cerba Research adding to its global network of... Read More »
PE-Backed Cardiovascular Associates of America Expands in Florida
Cardiovascular Associates of America (CVAUSA) announced its acquisition of The Cardiovascular Center of Florida. This is CVAUSA’s sixth transaction of 2023. The Cardiovascular Center of Florida operates two locations in Florida. According to its website, the practice is run by 26 physicians. CVAUSA is a physician management services organization headquartered in Celebration, Florida. Through CVAUSA’s physician-centered practice management model, physicians drive clinical care and their practice culture, while benefiting from the business expertise and shared resources available through CVAUSA. It was formed by Webster Equity Partners in 2021. Following the completion of... Read More »
EyeSouth Partners Acquires Retina and Vitreous of Texas
EyeSouth Partners announced on September 5 that it partnered with Retina and Vitreous of Texas, one of Houston’s leading retina-only practices. The affiliation represents EyeSouth’s thirty-eighth overall and the network’s first retina-only affiliation in the state of Texas. Financial terms of the deal were not disclosed. Retina and Vitreous of Texas has served the greater Houston market for more than 25 years, been involved in upwards of 180 medical publications and developed a nationally-renowned fellowship program that was originally established in 1997. According to its website, the practice is led by a team of six board-certified, fellowship-trained physicians. EyeSouth... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
